Latest / Stock Movers / MediaTek Rises, Innovent Jumps, Woodside Falls
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios Podcasts Radio News.
- 0:08Speaker 2: The Stock Movers Report, your roundup of companies making moves
- 0:12Speaker 2: in the stock market, harnessing the power of Bloomberg data.
- 0:16Speaker 1: Let's take a look at some stocks on the move
- 0:18Speaker 1: today in Asia. I'm Stephen Carroll with Caroline Hepker, and
- 0:21Speaker 1: we're joined by our markets reporter, Anthony Stevens. Anthony, let's start,
- 0:25Speaker 1: perhaps almost every day, it seems, with technology. Custom chips,
- 0:29Speaker 1: a big focus with the OpenAI build-out. How's that playing
- 0:32Speaker 1: out in the Asian session today?
- 0:34Speaker 3: That's a very interesting combination going into Nvidia earnings. You
- 0:38Speaker 3: have one of Nvidia's biggest customers coming out with competitive chips. Now,
- 0:42Speaker 3: OpenAI's chips are supposedly addressing the inference problems around LLM
- 0:48Speaker 3: models like it has itself. So it's also solving problems
- 0:51Speaker 3: for other LLMs. And why that's interesting is this custom
- 0:55Speaker 3: chip trend continues to accelerate even as Nvidia's own chips
- 0:59Speaker 3: are sold out. So At the moment, there is pretty
- 1:01Speaker 3: much insatiable demand for anything regarding computing power. But how
- 1:05Speaker 3: far that runway extends is a big question in the
- 1:08Speaker 3: Nvidia earnings. But for now, that's enough for investors in
- 1:11Speaker 3: Asia with the runway in Taiwan and Korea very clear.
- 1:14Speaker 3: You have the likes of MediaTek up 5.6%, Lagan is up,
- 1:20Speaker 3: limit up, and Samsung and Hynix continue their two-day rally.
- 1:23Speaker 3: They started off very weak yesterday and they've rallied around 6%
- 1:26Speaker 3: in a straight line.
- 1:28Speaker 4: Interesting. Pharmaceutical shares are also on the rise. What's driving that?
- 1:33Speaker 3: So this speaks to like a new dawn in terms
- 1:36Speaker 3: of drug development across a few technologies that's been brewing
- 1:39Speaker 3: for a while. So you have had that mRNA technology
- 1:43Speaker 3: that came out during COVID now finally being put to
- 1:45Speaker 3: use for other things, most notably skin cancer in the
- 1:48Speaker 3: case of Moderna. Moderna was up 14% overnight and that's
- 1:53Speaker 3: pretty much got all of the mRNA players in Asia
- 1:55Speaker 3: flying Most notably, CanSino, who again made the vaccines during COVID,
- 2:00Speaker 3: that's up 23% to start. And there have also been
- 2:03Speaker 3: some pretty strong earnings out of the Chinese pharma names
- 2:06Speaker 3: like Insino BioPharm and Innovant, which are being buoyed by
- 2:09Speaker 3: the Chinese success in the oncology space. Innovant, for example,
- 2:13Speaker 3: is up 9% today.
- 2:15Speaker 1: Meanwhile, the drop in oil prices is having an effect
- 2:18Speaker 1: on energy shares across Asia.
- 2:21Speaker 3: It has been interesting, right? As oil tracked higher, the
- 2:24Speaker 3: oil shares did keep up because margins on fuel products
- 2:28Speaker 3: are quite tight at the moment. The production capacity is
- 2:31Speaker 3: quite tight. So people did pile in to these oil names.
- 2:34Speaker 3: And now this shock kind of drop in oil on
- 2:36Speaker 3: the talks of Pakistan and Oman mediating a ceasefire. it
- 2:40Speaker 3: has really rocked positioning. You're seeing Woodside down almost 4%.
- 2:44Speaker 3: Ineos in Japan is underperforming the market sharply, down 2%.
- 2:49Speaker 3: And Eska Innovation is drastically underperforming the Korean bull market.
- 2:53Speaker 3: It's down 9%.
- 2:53Speaker 2: Yeah.
- 2:56Speaker 4: Very interesting isn't it in terms of all markets i
- 2:59Speaker 4: mean i'm just kind of going back to the pharmaceutical
- 3:01Speaker 4: story though that you mentioned um a moderna share price
- 3:04Speaker 4: last week spiking that that huge number 177 i mean
- 3:09Speaker 4: it was extraordinary wasn't it the kind of idea of
- 3:11Speaker 4: personalized vaccines and this in that late stage trial being
- 3:15Speaker 4: able to maybe uh reduce the recurrence of melanoma of
- 3:19Speaker 4: this the kind of deadliest skin cancer i mean yeah
- 3:22Speaker 4: it's hugely significant isn't it um Briefly, Antony, what do
- 3:27Speaker 4: you think of the Besant story about bond buybacks? I mean,
- 3:31Speaker 4: this is the big debate in bond markets, isn't it?
- 3:33Speaker 4: How much of a put is there in markets and
- 3:36Speaker 4: the size and scale of the US Treasury market? What
- 3:39Speaker 4: do you think of it?
- 3:40Speaker 3: There are two separate debates going on here. The first
- 3:43Speaker 3: debate is how long can you pull this off for?
- 3:46Speaker 3: How sustainable is it versus the pure fundamentals of the
- 3:50Speaker 3: US economy? And on that front, you had Stanley Druckenmiller
- 3:52Speaker 3: saying that it's not long-term feasible and so many others, right,
- 3:56Speaker 3: who point to the fact that the structural deficit in
- 3:58Speaker 3: the US is the big problem pushing on yields alongside
- 4:02Speaker 3: the kind of deluge of AI debt that's coming as well.
- 4:05Speaker 3: But on the short-term side of things, he is leaning
- 4:09Speaker 3: into a very crowded trade. So he may be trying
- 4:12Speaker 3: to just trigger a short squeeze, right? You have very
- 4:14Speaker 3: extended positioning in ultra long bond futures. You have very
- 4:17Speaker 3: extended positioning in options on the same trade. While yields
- 4:22Speaker 3: are quite high and you do have real money that
- 4:25Speaker 3: needs to be put to work at those yield levels.
- 4:29Speaker 3: So he may just be needing to trigger a short
- 4:31Speaker 3: squeeze to get what he wants while the situation with
- 4:34Speaker 3: Iran is being worked out. So in terms of timing,
- 4:37Speaker 3: it's very kind of a nuanced thing for people putting
- 4:40Speaker 3: on this trade. You can put it on structurally, but
- 4:43Speaker 3: you need to have the risk tolerance to let it
- 4:45Speaker 3: run for a little while.
- 4:48Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 4:52Speaker 2: us throughout the day for the latest roundup of companies
- 4:55Speaker 2: making news on Wall Street. And for the latest market-moving headlines,
- 4:59Speaker 2: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 5:03Speaker 2: and on Apple CarPlay and Android Auto with the Bloomberg
- 5:06Speaker 2: Business app.